Petter Quist-Paulsen
Overview
Explore the profile of Petter Quist-Paulsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taalas T, Oskarsson T, Heyman M, Lund B, Lepik K, Vaitkeviciene G, et al.
Haematologica
. 2025 Feb;
PMID: 39973352
Age and sex have historically been associated with differences in acute lymphoblastic leukemia (ALL) survival. In the NOPHO ALL2008 trial, patients aged 1-45 years with BCR::ABL1-negative B-precursor and Tcell ALL...
2.
Behsen A, Vandsemb E, Schmidt Slordahl T, Hjorth-Hansen H, Quist-Paulsen P, Misund K, et al.
Haematologica
. 2023 Oct;
109(4):1301-1305.
PMID: 37794808
No abstract available.
3.
Egnell C, Hallbook H, Heyman M, Wartiovaara-Kautto U, Quist-Paulsen P, Schmiegelow K, et al.
Acta Oncol
. 2023 Sep;
62(12):1723-1731.
PMID: 37725524
Background: Data on outcome for patients in different body mass index (BMI) categories in young adults with acute lymphoblastic leukemia (ALL) are scarce. We explored survival and toxicities in different...
4.
Noren-Nystrom U, Andersen M, Barbany G, Dirse V, Eilert-Olsen M, Engvall M, et al.
Hemasphere
. 2023 May;
7(5):e883.
PMID: 37153872
No abstract available.
5.
Skipper M, Rank C, Brunsvig Jarvis K, Stensig Lynggaard L, Andres-Jensen L, Quist-Paulsen P, et al.
EJHaem
. 2022 Sep;
3(3):754-763.
PMID: 36051071
Cerebral sinovenous thrombosis (CSVT) is a serious complication during asparaginase therapy in patients with acute lymphoblastic leukaemia (ALL). We identified 46 patients with CSVT among 2651 patients (1‒45 years) treated...
6.
Larsen T, Garresori H, Brekke J, Enden T, Froen H, Jacobsen E, et al.
J Thromb Haemost
. 2022 Jul;
20(8):1937-1939.
PMID: 35859282
No abstract available.
7.
Larsen T, Garresori H, Brekke J, Enden T, Froen H, Jacobsen E, et al.
J Thromb Haemost
. 2022 Feb;
20(5):1166-1181.
PMID: 35114046
Background: There are no data on the effect of low-dose anticoagulation as secondary prophylaxis for venous thromboembolism (VTE) in cancer patients. We assessed the efficacy and safety of low-dose apixaban...
8.
Christensen E, Foss O, Quist-Paulsen P, Staur I, Pettersen F, Holien T, et al.
Pharmaceutics
. 2021 Oct;
13(10).
PMID: 34683851
Extracorporeal photopheresis (ECP), an immunomodulatory therapy for the treatment of chronic graft-versus-host disease (cGvHD), exposes isolated white blood cells to photoactivatable 8-methoxypsoralen (8-MOP) and UVA light to induce the apoptosis...
9.
Andres-Jensen L, Grell K, Rank C, Albertsen B, Tuckuviene R, Nielsen R, et al.
Leukemia
. 2021 Aug;
36(2):361-369.
PMID: 34389803
Endothelial dysfunction has not previously been investigated as a thrombogenic risk factor among patients with acute lymphoblastic leukemia (ALL), known to be at high risk of thromboembolism. We retrospectively explored...
10.
Toksvang L, Grell K, Nersting J, Degn M, Nielsen S, Abrahamsson J, et al.
Leukemia
. 2021 Jun;
36(1):33-41.
PMID: 34175901
Methotrexate/6-mercaptopurine maintenance therapy improves acute lymphoblastic leukemia (ALL) outcome. Cytotoxicity is mediated by DNA incorporation of thioguanine nucleotides (DNA-TG). We investigated the association of DNA-TG to relapse risk in 1 ...